• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Public Health . Rapid Community Engagement in Response to SARS-CoV-2 Funding Opportunities: New York City, 2020‒2021

tetano

Editor, Senior Moderator
Am J Public Health


. 2022 Nov;112(S9):S904-S908.
doi: 10.2105/AJPH.2022.307072.
Rapid Community Engagement in Response to SARS-CoV-2 Funding Opportunities: New York City, 2020‒2021


Natasha J Williams[SUP] 1 [/SUP], Emily Gill[SUP] 1 [/SUP], Malcolm A Punter[SUP] 1 [/SUP], Jeremy Reiss[SUP] 1 [/SUP], Melody Goodman[SUP] 1 [/SUP], Donna Shelley[SUP] 1 [/SUP], Lorna E Thorpe[SUP] 1 [/SUP]



Affiliations

Abstract

In response to fast-turnaround funding opportunities, collaborations have been forming across the country to address severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disparities. Here we describe the process, notes from the field, and evaluation results from a new collaboration involving multiple partners, formed in October 2020 in New York City as part of the Rapid Acceleration of Diagnostics initiative. We used the validated Research Engagement Survey Tool to evaluate the partnership. Results can inform future research and improve engagement efforts aimed at reducing SARS-CoV-2 disparities. (Am J Public Health. 2022;112(S9):S904-S908. https://doi.org/10.2105/AJPH.2022.307072).
 
Back
Top Bottom